<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Med Genet</journal-id><journal-title>BMC Medical Genetics</journal-title><issn pub-type="epub">1471-2350</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1471-2350-8-51</article-id><article-id pub-id-type="pmid">17683561</article-id><article-id pub-id-type="doi">10.1186/1471-2350-8-51</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>The <italic>TCF7L2 </italic>locus and type 1 diabetes</article-title></title-group><contrib-group><contrib id="A1" contrib-type="author"><name><surname>Qu</surname><given-names>Hui-Qi</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>hui.qi.qu@mail.mcgill.ca</email></contrib><contrib id="A2" corresp="yes" contrib-type="author"><name><surname>Polychronakos</surname><given-names>Constantin</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I2">2</xref><email>constantin.polychronakos@mcgill.ca</email></contrib></contrib-group><aff id="I1"><label>1</label>Endocrine Genetics Lab, The McGill University Health Center (Montreal Children's Hospital), Montr&#x000e9;al, Qu&#x000e9;bec, Canada</aff><aff id="I2"><label>2</label>The McGill University Health Center (Montreal Children's Hospital), 2300 Tupper, Montr&#x000e9;al, Qu&#x000e9;bec, H3H 1P3, Canada</aff><pub-date pub-type="collection"><year>2007</year></pub-date><pub-date pub-type="epub"><day>3</day><month>8</month><year>2007</year></pub-date><volume>8</volume><fpage>51</fpage><lpage>51</lpage><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2350/8/51"/><history><date date-type="received"><day>28</day><month>11</month><year>2006</year></date><date date-type="accepted"><day>3</day><month>8</month><year>2007</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2007 Qu and Polychronakos; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2007</copyright-year><copyright-holder>Qu and Polychronakos; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p><!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author> Qu Hui-Qi hui.qi.qu@mail.mcgill.ca </dc:author><dc:title> The TCF7L2 locus and type 1 diabetes </dc:title><dc:date>2007</dc:date><dcterms:bibliographicCitation>BMC Medical Genetics 8(1): 51-. (2007)</dcterms:bibliographicCitation><dc:identifier type="sici">1471-2350(2007)8:1&#x0003c;51&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1471-2350</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>--></license></permissions><abstract><sec><title>Background</title><p><italic>TCF7L2 </italic>belongs to a subfamily of TCF7-like HMG box-containing transcription factors, and maps to human chromosome 10q25.3. A recent study identified genetic association of type 2 diabetes (T2D) with this gene, correlated with diminished insulin secretion. This study aimed to investigate the possibility of genetic association between <italic>TCF7L2 </italic>and type 1 diabetes (T1D).</p></sec><sec sec-type="methods"><title>Methods</title><p>The SNP most significantly associated with T2D, rs7903146, was genotyped in 886 T1D nuclear family trios with ethnic backgrounds of mixed European descent.</p></sec><sec><title>Results</title><p>This study found no T1D association with, and no age-of-onset effect from rs7903146.</p></sec><sec><title>Conclusion</title><p>This study suggests that a T2D mechanism mediated by <italic>TCF7L2 </italic>does not participate in the etiology of T1D.</p></sec></abstract></article-meta></front><body><sec><title>Background</title><p>Recently, a new type 2 diabetes (T2D) susceptibility gene, transcription factor 7-like 2 (<italic>TCF7L2</italic>), was identified[<xref ref-type="bibr" rid="B1">1</xref>]. Subsequently, many studies confirmed this novel association[<xref ref-type="bibr" rid="B2">2</xref>-<xref ref-type="bibr" rid="B12">12</xref>], which accounts for the highest T2D risk confirmed to date. <italic>TCF7L2 </italic>belongs to a subfamily of TCF7-like HMG box-containing transcription factors, and maps to human chromosome 10q25.3[<xref ref-type="bibr" rid="B13">13</xref>]. It is a component of the Wnt signaling pathway, and participates in the tissue-specific regulation of expression of proglucagon gene, which has been shown critical in blood glucose homeostasis[<xref ref-type="bibr" rid="B14">14</xref>]. Because of the effects on blood glucose homeostasis, the <italic>TCF7L2 </italic>gene variation may also be important in type 1 diabetes (T1D). To investigate the possibility of this association, we genotyped the marker most significantly associated with T2D, the intronic SNP rs7903146, in our T1D family collection.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Subjects</title><p>Genomic DNA (gDNA) was obtained after informed consent from T1D-affected subjects and their two parents (886 trios or 2,658 individuals after removing families with Mendelian discrepancies at multiple independent SNPs). The Research Ethics Board of the Montreal Children's Hospital and other participating centers approved the study. Ethnic backgrounds were of mixed European descent, with the largest single group being of Quebec French-Canadian origin (40% of the total collection).</p></sec><sec><title>SNP Genotyping</title><p>The SNP rs7903146 was genotyped by the Sequenom MassARRAY system (Sequenom, San Diego CA, USA). Primers for PCR and MassEXTEND reaction to detect sequence differences at the single nucleotide level were designed using Assay Design software. PCR primers: forward, 5'-ACGTTGGATGGGTGCCTCATACGGCAATTA-3'; reverse, 5'-ACGTTGGATGTCTCTGCCTCAAAACCTAGC-3'. The extension primer, 5'-AGAGCTAAGCACTTTTTAGATA-3'. We amplified 2.5 ng of gDNA in a 5 &#x003bc;l volume. After dephosphorylation of unincorporated dNTPs, allele-specific primer extension reaction was performed to generate different sizes of extension products corresponding to each allele by the Sequenom iPLEX&#x02122; technology. Samples were conditioned to remove extraneous salts and genotypes were called based on the presence of different sizes of extension products by the Matrix Assisted Laser Desorption Ionization Time Of Flight (MALDI-TOF) mass spectrometry technology[<xref ref-type="bibr" rid="B15">15</xref>]. The call rate of this SNP is 99.6% and the Mendelian error rate is 0.2%.</p></sec><sec><title>Statistics</title><p>Hardy-Weinberg equilibrium (HWE) of the genotype distribution in parents of the T1D families was tested by the following equation.</p><p><disp-formula><mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M1" name="1471-2350-8-51-i1" overflow="scroll"><mml:semantics definitionURL="" encoding=""><mml:mrow><mml:msup><mml:mi>&#x003c7;</mml:mi><mml:mn>2</mml:mn></mml:msup><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mtext>a</mml:mtext><mml:mo>+</mml:mo><mml:mtext>b</mml:mtext><mml:mo>+</mml:mo><mml:mtext>c</mml:mtext><mml:mo stretchy="false">)</mml:mo><mml:msup><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msup><mml:mtext>b</mml:mtext><mml:mn>2</mml:mn></mml:msup><mml:mo>&#x02212;</mml:mo><mml:mn>4</mml:mn><mml:mtext>ac</mml:mtext><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mn>2</mml:mn><mml:mtext>a</mml:mtext><mml:mo>+</mml:mo><mml:mtext>b</mml:mtext><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:msup><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mtext>b</mml:mtext><mml:mo>+</mml:mo><mml:mn>2</mml:mn><mml:mtext>c</mml:mtext><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mfrac><mml:mo>,</mml:mo></mml:mrow><mml:annotation encoding="MathType-MTEF"> MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacqaHhpWydaahaaWcbeqaaiabikdaYaaakiabg2da9maalaaabaGaeiikaGIaeeyyaeMaey4kaSIaeeOyaiMaey4kaSIaee4yamMaeiykaKIaeiikaGIaeeOyai2aaWbaaSqabeaacqaIYaGmaaGccqGHsislcqaI0aancqqGHbqycqqGJbWycqGGPaqkdaahaaWcbeqaaiabikdaYaaaaOqaaiabcIcaOiabikdaYiabbggaHjabgUcaRiabbkgaIjabcMcaPmaaCaaaleqabaGaeGOmaidaaOGaeiikaGIaeeOyaiMaey4kaSIaeGOmaiJaee4yamMaeiykaKYaaWbaaSqabeaacqaIYaGmaaaaaOGaeiilaWcaaa@512B@</mml:annotation></mml:semantics></mml:math></disp-formula></p><p>&#x003bd; = 1; a, b and c are the frequencies of, respectively, the C/C, C/T or T/T genotypes.</p><p>Transmission disequilibrium test (TDT) was performed by the Haploview software[<xref ref-type="bibr" rid="B16">16</xref>]. The age effect among different genotypes was tested by both ANOVA and the nonparametric Kruskal-Wallis Test.</p></sec></sec><sec><title>Results and discussion</title><p>The minor allele T of rs7903146 has a frequency of 0.303 in the parents of the T1D families, which is similar to the frequencies of control groups in the T2D studies. The genotype distribution in the parents was in HWE (&#x003c7;<sup>2 </sup>= 0.0, &#x003bd; = 1, p = 0.972), compatible with the absence of stratification, admixture or technical artifacts. Our study found no T1D association from rs7903146. The transmission ratio T/C = 369/342 (<bold>&#x003c7;<sup>2 </sup></bold>= 1.0, p = 0.311).</p><p>For a SNP with the minor allele frequency of 0.303, the statistical power at &#x003b1; = 0.05 level of our family-based association study on 886 affected nuclear family trios is shown in Figure <xref ref-type="fig" rid="F1">1</xref>. Our study has a statistic power of &#x0003e; 80% at &#x003b1; = 0.05 level to detect a genetic association with an effect size as low as OR = 1.23. Besides the <italic>HLA </italic>region[<xref ref-type="bibr" rid="B17">17</xref>], previously confirmed T1D associations have been replicable in our dataset, including the weak effect from the SNP rs231775 on the <italic>CTLA4 </italic>gene(Table <xref ref-type="table" rid="T1">1</xref>). Considering the important role of <italic>TCF7L2 </italic>in glucose homeostasis, one possibility that needs to be excluded is that the <italic>TCF7L2 </italic>gene variation might accelerate the onset of clinical symptoms of T1D. We compared the age-of-onset of different genotypes of the <italic>TCF7L2 </italic>rs7903146 (Table <xref ref-type="table" rid="T2">2</xref>). We found no age-of-onset effect from the <italic>TCF7L2 </italic>variation. Therefore, our result suggests that the genetic variation of <italic>TCF7L2 </italic>has no obvious effect on T1D.</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Transmission disequilibrium tests of the SNPs in the <italic>INS</italic>, <italic>PTPN22</italic>, and <italic>CTLA4 </italic>gene in the T1D trio set used in this study</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="center"><bold>gene</bold></td><td align="center"><bold>dbSNP ID</bold></td><td align="center"><bold>minor allele (frequency)</bold></td><td align="center"><bold>Transmission ratio*</bold></td><td align="center"><bold>&#x003c7;</bold><sup>2 </sup>(p value)</td><td align="center">OR (95% CI)</td></tr></thead><tbody><tr><td align="center"><bold><italic>INS</italic></bold></td><td align="center">rs689</td><td align="center">T (0.207)</td><td align="center">186:387</td><td align="center">70.5 (4.58 &#x000d7; 10<sup>-17</sup>)</td><td align="center">0.48 (0.40, 0.57)</td></tr><tr><td align="center"><bold><italic>PTPN22</italic></bold></td><td align="center">rs2476601</td><td align="center">A (0.126)</td><td align="center">251:123</td><td align="center">43.8 (3.62 &#x000d7; 10<sup>-11</sup>)</td><td align="center">2.04 (1.64, 2.53)</td></tr><tr><td align="center"><bold><italic>CTLA4</italic></bold></td><td align="center">rs231775</td><td align="center">G (0.387)</td><td align="center">443:382</td><td align="center">4.5 (0.034)</td><td align="center">1.16 (1.01, 1.33)</td></tr><tr><td align="center"><bold><italic>CTLA4</italic></bold></td><td align="center">rs5742909</td><td align="center">T (0.090)</td><td align="center">137:178</td><td align="center">5.3 (0.021)</td><td align="center">0.77 (0.62, 0.96)</td></tr></tbody></table><table-wrap-foot><p>* Minor allele transmitted : untransmitted.</p></table-wrap-foot></table-wrap><table-wrap position="float" id="T2"><label>Table 2</label><caption><p>The age-of-onset of T1D of three rs7903146 genotypes</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left">genotype</td><td align="left">number</td><td align="left">average age-of-onset (<inline-formula><mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M2" name="1471-2350-8-51-i2" overflow="scroll"><mml:semantics definitionURL="" encoding=""><mml:mover accent="true"><mml:mtext>x</mml:mtext><mml:mo>&#x000af;</mml:mo></mml:mover><mml:annotation encoding="MathType-MTEF"> MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuqG4baEgaqeaaaa@2E3B@</mml:annotation></mml:semantics></mml:math></inline-formula> &#x000b1; <italic>s</italic>)</td><td align="left">Median</td></tr></thead><tbody><tr><td align="left">C/C</td><td align="left">355</td><td align="left">8.1 &#x000b1; 4.3</td><td align="left">8.3</td></tr><tr><td align="left">C/T</td><td align="left">323</td><td align="left">8.8 &#x000b1; 5.6</td><td align="left">8.1</td></tr><tr><td align="left">T/T</td><td align="left">74</td><td align="left">8.3 &#x000b1; 5.6</td><td align="left">7.6</td></tr><tr><td align="left">F value (p)</td><td></td><td align="left">F = 1.540 (p = 0.215)</td><td></td></tr><tr><td align="left">Kruskal Wallis test</td><td></td><td align="left">&#x003c7;<sup>2 </sup>= 1.427 (p = 0.490)</td><td></td></tr></tbody></table></table-wrap><fig position="float" id="F1"><label>Figure 1</label><caption><p>The statistical power of this study to detect a genetic association with the minor allele frequency of 0.303 at &#x003b1; = 0.05 level. X-axis: the OR value; Y-axis: the statistical power.</p></caption><graphic xlink:href="1471-2350-8-51-1"/></fig><p><italic>TCF7L2 </italic>encodes a transcription factor, also known as T-cell transcription factor 4 (TCF4). TCF4 acts through binding with &#x003b2;-catenin as a complex, and consequently activates the expression of TCF4-regulated genes[<xref ref-type="bibr" rid="B18">18</xref>,<xref ref-type="bibr" rid="B19">19</xref>]. How the <italic>TCF7L2 </italic>variation changes the gene function is unclear yet. TCF4 is a 596aa peptide (NP_110383.1), which contains two conserved domains, the CTNNB1_binding domain and the SOX-TCF_HMG-box domain. The CTNNB1_binding domain locates from the 1<sup>st </sup>to the 236<sup>th </sup>amino acid, which binds to &#x003b2;-catenin and forms the active complex. The SOX-TCF_HMG-box domain locates from the 330<sup>th </sup>to the 397<sup>th </sup>amino acid, which binds to specific DNA motif and regulates gene transcription. Sequencing of all the exons of <italic>TCF7L2 </italic>in 184 individuals (93 T2D cases and 91 controls) has found no nonsynonymous SNP (nsSNP)[<xref ref-type="bibr" rid="B1">1</xref>]. The possibility of protein-sequence polymorphism can be excluded as the basis for the T2D susceptibility. Therefore, the T2D susceptibility should be from the change of gene expression level resulting from regulatory genetic variation. The <italic>TCF7L2 </italic>gene spans ~216 kb and ~750 SNPs have been identified in this region. As shown by the international HapMap project data, <italic>TCF7L2 </italic>spans several linkage disequilibrium (LD) blocks in Europeans[<xref ref-type="bibr" rid="B20">20</xref>]. The T2D-associated SNPs are from the largest LD block spanning ~65 kb, which starts from the middle of intron 3, and ends at the first seventh of intron 4[<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B21">21</xref>]. The genetic regulation on <italic>TCF7L2 </italic>expression can be from the change of mRNA processing or alternative splicing from a variation in the gene intronic region. There is no published information on any such effects; unpublished data from our lab (Marchand et al., work in progress) has failed to find allelic effects on mRNA levels or relative abundance of splicing isoforms in the few tissues examined to date.</p><p>T2D results from a progressive insulin secretory defect on a background of insulin resistance[<xref ref-type="bibr" rid="B22">22</xref>]. However, the role of <italic>TCF7L2 </italic>in the T2D mechanism is unclear. Present studies show contradictory results on the effect of the <italic>TCF7L2 </italic>gene variation on insulin secretion and insulin sensitivity. Florez JC, et al, showed that the T2D-predisposing haplotype correlates with diminished insulin secretion but has no effect on insulin response[<xref ref-type="bibr" rid="B3">3</xref>]. On the other hand, Elbein SC, et al, showed that the <italic>TCF7L2 </italic>gene variation is correlated with reduced glucose tolerance and insulin sensitivity, but not insulin secretion[<xref ref-type="bibr" rid="B23">23</xref>]. In either case, it would have been reasonable to hypothesize that the T2D-risk genotypes at <italic>TCF7L2 </italic>may accelerate the clinical onset of T1D symptoms; none was seen in our study.</p></sec><sec><title>Conclusion</title><p>Our study suggests the <italic>TCF7L2 </italic>gene variation does not participate in the etiology of T1D. During the manuscript preparation of this study, another report of no association between T1D and <italic>TCF7L2 </italic>was published, which is concordant with our conclusion[<xref ref-type="bibr" rid="B24">24</xref>]. The combined results of both studies clearly show that the genetic susceptibility from the <italic>TCF7L2 </italic>gene variation is a unique mechanism of T2D, and is not shared by T1D.</p></sec><sec><title>Abbreviations</title><p>T1D, type 1 diabetes; T2D, type 2 diabetes; <italic>TCF7L2</italic>, transcription factor 7-like 2; <italic>INS</italic>, insulin; SNP, single-nucleotide polymorphism; TDT, Transmission disequilibrium test</p></sec><sec><title>Competing interests</title><p>The author(s) declare that they have no competing interests.</p></sec><sec><title>Authors' contributions</title><p>HQQ carried out the implementation and analysis, and drafted the manuscript. CP conceived of the study, participated in its design and coordination, and participated in preparation of the manuscript. Both authors approved the final manuscript.</p></sec><sec><title>Pre-publication history</title><p>The pre-publication history for this paper can be accessed here:</p><p><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2350/8/51/prepub"/></p></sec></body><back><ack><sec><title>Acknowledgements</title><p>This work was funded by the Juvenile Diabetes Research Foundation International and Genome Canada through the Ontario Genomics Institute. H.Q.Q. is supported by a fellowship from the Canadian Institutes of Health Research.</p></sec></ack><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Grant</surname><given-names>SF</given-names></name><name><surname>Thorleifsson</surname><given-names>G</given-names></name><name><surname>Reynisdottir</surname><given-names>I</given-names></name><name><surname>Benediktsson</surname><given-names>R</given-names></name><name><surname>Manolescu</surname><given-names>A</given-names></name><name><surname>Sainz</surname><given-names>J</given-names></name><name><surname>Helgason</surname><given-names>A</given-names></name><name><surname>Stefansson</surname><given-names>H</given-names></name><name><surname>Emilsson</surname><given-names>V</given-names></name><name><surname>Helgadottir</surname><given-names>A</given-names></name><name><surname>Styrkarsdottir</surname><given-names>U</given-names></name><name><surname>Magnusson</surname><given-names>KP</given-names></name><name><surname>Walters</surname><given-names>GB</given-names></name><name><surname>Palsdottir</surname><given-names>E</given-names></name><name><surname>Jonsdottir</surname><given-names>T</given-names></name><name><surname>Gudmundsdottir</surname><given-names>T</given-names></name><name><surname>Gylfason</surname><given-names>A</given-names></name><name><surname>Saemundsdottir</surname><given-names>J</given-names></name><name><surname>Wilensky</surname><given-names>RL</given-names></name><name><surname>Reilly</surname><given-names>MP</given-names></name><name><surname>Rader</surname><given-names>DJ</given-names></name><name><surname>Bagger</surname><given-names>Y</given-names></name><name><surname>Christiansen</surname><given-names>C</given-names></name><name><surname>Gudnason</surname><given-names>V</given-names></name><name><surname>Sigurdsson</surname><given-names>G</given-names></name><name><surname>Thorsteinsdottir</surname><given-names>U</given-names></name><name><surname>Gulcher</surname><given-names>JR</given-names></name><name><surname>Kong</surname><given-names>A</given-names></name><name><surname>Stefansson</surname><given-names>K</given-names></name></person-group><article-title>Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes</article-title><source>Nat Genet</source><year>2006</year><volume>38</volume><fpage>320</fpage><lpage>323</lpage><pub-id pub-id-type="pmid">16415884</pub-id><pub-id pub-id-type="doi">10.1038/ng1732</pub-id></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Todd</surname><given-names>JA</given-names></name></person-group><article-title>Statistical false positive or true disease pathway?</article-title><source>Nat Genet</source><year>2006</year><volume>38</volume><fpage>731</fpage><lpage>733</lpage><pub-id pub-id-type="pmid">16804532</pub-id><pub-id pub-id-type="doi">10.1038/ng0706-731</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Florez</surname><given-names>JC</given-names></name><name><surname>Jablonski</surname><given-names>KA</given-names></name><name><surname>Bayley</surname><given-names>N</given-names></name><name><surname>Pollin</surname><given-names>TI</given-names></name><name><surname>de Bakker</surname><given-names>PI</given-names></name><name><surname>Shuldiner</surname><given-names>AR</given-names></name><name><surname>Knowler</surname><given-names>WC</given-names></name><name><surname>Nathan</surname><given-names>DM</given-names></name><name><surname>Altshuler</surname><given-names>D</given-names></name></person-group><article-title>TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program</article-title><source>N Engl J Med</source><year>2006</year><volume>355</volume><fpage>241</fpage><lpage>250</lpage><pub-id pub-id-type="pmid">16855264</pub-id><pub-id pub-id-type="doi">10.1056/NEJMoa062418</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Groves</surname><given-names>CJ</given-names></name><name><surname>Zeggini</surname><given-names>E</given-names></name><name><surname>Minton</surname><given-names>J</given-names></name><name><surname>Frayling</surname><given-names>TM</given-names></name><name><surname>Weedon</surname><given-names>MN</given-names></name><name><surname>Rayner</surname><given-names>NW</given-names></name><name><surname>Hitman</surname><given-names>GA</given-names></name><name><surname>Walker</surname><given-names>M</given-names></name><name><surname>Wiltshire</surname><given-names>S</given-names></name><name><surname>Hattersley</surname><given-names>AT</given-names></name><name><surname>McCarthy</surname><given-names>MI</given-names></name></person-group><article-title>Association analysis of 6,736 U.K. subjects provides replication and confirms TCF7L2 as a type 2 diabetes susceptibility gene with a substantial effect on individual risk</article-title><source>Diabetes</source><year>2006</year><volume>55</volume><fpage>2640</fpage><lpage>2644</lpage><pub-id pub-id-type="pmid">16936215</pub-id><pub-id pub-id-type="doi">10.2337/db06-0355</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Qi</surname><given-names>L</given-names></name><name><surname>Hunter</surname><given-names>DJ</given-names></name><name><surname>Meigs</surname><given-names>JB</given-names></name><name><surname>Manson</surname><given-names>JE</given-names></name><name><surname>van Dam</surname><given-names>RM</given-names></name><name><surname>Hu</surname><given-names>FB</given-names></name></person-group><article-title>Variant of transcription factor 7-like 2 (TCF7L2) gene and the risk of type 2 diabetes in large cohorts of U.S. women and men</article-title><source>Diabetes</source><year>2006</year><volume>55</volume><fpage>2645</fpage><lpage>2648</lpage><pub-id pub-id-type="pmid">16936216</pub-id><pub-id pub-id-type="doi">10.2337/db06-0643</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Scott</surname><given-names>LJ</given-names></name><name><surname>Bonnycastle</surname><given-names>LL</given-names></name><name><surname>Willer</surname><given-names>CJ</given-names></name><name><surname>Sprau</surname><given-names>AG</given-names></name><name><surname>Jackson</surname><given-names>AU</given-names></name><name><surname>Narisu</surname><given-names>N</given-names></name><name><surname>Duren</surname><given-names>WL</given-names></name><name><surname>Chines</surname><given-names>PS</given-names></name><name><surname>Stringham</surname><given-names>HM</given-names></name><name><surname>Erdos</surname><given-names>MR</given-names></name><name><surname>Valle</surname><given-names>TT</given-names></name><name><surname>Tuomilehto</surname><given-names>J</given-names></name><name><surname>Bergman</surname><given-names>RN</given-names></name><name><surname>Mohlke</surname><given-names>KL</given-names></name><name><surname>Collins</surname><given-names>FS</given-names></name><name><surname>Boehnke</surname><given-names>M</given-names></name></person-group><article-title>Association of transcription factor 7-like 2 (TCF7L2) variants with type 2 diabetes in a Finnish sample</article-title><source>Diabetes</source><year>2006</year><volume>55</volume><fpage>2649</fpage><lpage>2653</lpage><pub-id pub-id-type="pmid">16936217</pub-id><pub-id pub-id-type="doi">10.2337/db06-0341</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Damcott</surname><given-names>CM</given-names></name><name><surname>Pollin</surname><given-names>TI</given-names></name><name><surname>Reinhart</surname><given-names>LJ</given-names></name><name><surname>Ott</surname><given-names>SH</given-names></name><name><surname>Shen</surname><given-names>H</given-names></name><name><surname>Silver</surname><given-names>KD</given-names></name><name><surname>Mitchell</surname><given-names>BD</given-names></name><name><surname>Shuldiner</surname><given-names>AR</given-names></name></person-group><article-title>Polymorphisms in the transcription factor 7-like 2 (TCF7L2) gene are associated with type 2 diabetes in the Amish: replication and evidence for a role in both insulin secretion and insulin resistance</article-title><source>Diabetes</source><year>2006</year><volume>55</volume><fpage>2654</fpage><lpage>2659</lpage><pub-id pub-id-type="pmid">16936218</pub-id><pub-id pub-id-type="doi">10.2337/db06-0338</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saxena</surname><given-names>R</given-names></name><name><surname>Gianniny</surname><given-names>L</given-names></name><name><surname>Burtt</surname><given-names>NP</given-names></name><name><surname>Lyssenko</surname><given-names>V</given-names></name><name><surname>Giuducci</surname><given-names>C</given-names></name><name><surname>Sjogren</surname><given-names>M</given-names></name><name><surname>Florez</surname><given-names>JC</given-names></name><name><surname>Almgren</surname><given-names>P</given-names></name><name><surname>Isomaa</surname><given-names>B</given-names></name><name><surname>Orho-Melander</surname><given-names>M</given-names></name><name><surname>Lindblad</surname><given-names>U</given-names></name><name><surname>Daly</surname><given-names>MJ</given-names></name><name><surname>Tuomi</surname><given-names>T</given-names></name><name><surname>Hirschhorn</surname><given-names>JN</given-names></name><name><surname>Ardlie</surname><given-names>KG</given-names></name><name><surname>Groop</surname><given-names>LC</given-names></name><name><surname>Altshuler</surname><given-names>D</given-names></name></person-group><article-title>Common single nucleotide polymorphisms in TCF7L2 are reproducibly associated with type 2 diabetes and reduce the insulin response to glucose in nondiabetic individuals</article-title><source>Diabetes</source><year>2006</year><volume>55</volume><fpage>2890</fpage><lpage>2895</lpage><pub-id pub-id-type="pmid">17003358</pub-id><pub-id pub-id-type="doi">10.2337/db06-0381</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cauchi</surname><given-names>S</given-names></name><name><surname>Meyre</surname><given-names>D</given-names></name><name><surname>Dina</surname><given-names>C</given-names></name><name><surname>Choquet</surname><given-names>H</given-names></name><name><surname>Samson</surname><given-names>C</given-names></name><name><surname>Gallina</surname><given-names>S</given-names></name><name><surname>Balkau</surname><given-names>B</given-names></name><name><surname>Charpentier</surname><given-names>G</given-names></name><name><surname>Pattou</surname><given-names>F</given-names></name><name><surname>Stetsyuk</surname><given-names>V</given-names></name><name><surname>Scharfmann</surname><given-names>R</given-names></name><name><surname>Staels</surname><given-names>B</given-names></name><name><surname>Fruhbeck</surname><given-names>G</given-names></name><name><surname>Froguel</surname><given-names>P</given-names></name></person-group><article-title>Transcription factor TCF7L2 genetic study in the French population: expression in human beta-cells and adipose tissue and strong association with type 2 diabetes</article-title><source>Diabetes</source><year>2006</year><volume>55</volume><fpage>2903</fpage><lpage>2908</lpage><pub-id pub-id-type="pmid">17003360</pub-id><pub-id pub-id-type="doi">10.2337/db06-0474</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Weedon</surname><given-names>MN</given-names></name><name><surname>McCarthy</surname><given-names>MI</given-names></name><name><surname>Hitman</surname><given-names>G</given-names></name><name><surname>Walker</surname><given-names>M</given-names></name><name><surname>Groves</surname><given-names>CJ</given-names></name><name><surname>Zeggini</surname><given-names>E</given-names></name><name><surname>Rayner</surname><given-names>NW</given-names></name><name><surname>Shields</surname><given-names>B</given-names></name><name><surname>Owen</surname><given-names>KR</given-names></name><name><surname>Hattersley</surname><given-names>AT</given-names></name><name><surname>Frayling</surname><given-names>TM</given-names></name></person-group><article-title>Combining Information from Common Type 2 Diabetes Risk Polymorphisms Improves Disease Prediction</article-title><source>PLoS Med</source><year>2006</year><volume>3</volume><pub-id pub-id-type="pmid">17020404</pub-id></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>van Vliet-Ostaptchouk</surname><given-names>JV</given-names></name><name><surname>Shiri-Sverdlov</surname><given-names>R</given-names></name><name><surname>Zhernakova</surname><given-names>A</given-names></name><name><surname>Strengman</surname><given-names>E</given-names></name><name><surname>van Haeften</surname><given-names>TW</given-names></name><name><surname>Hofker</surname><given-names>MH</given-names></name><name><surname>Wijmenga</surname><given-names>C</given-names></name></person-group><article-title>Association of variants of transcription factor 7-like 2 (TCF7L2) with susceptibility to type 2 diabetes in the Dutch Breda cohort</article-title><source>Diabetologia</source><year>2006</year><pub-id pub-id-type="pmid">17031610</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Humphries</surname><given-names>SE</given-names></name><name><surname>Gable</surname><given-names>D</given-names></name><name><surname>Cooper</surname><given-names>JA</given-names></name><name><surname>Ireland</surname><given-names>H</given-names></name><name><surname>Stephens</surname><given-names>JW</given-names></name><name><surname>Hurel</surname><given-names>SJ</given-names></name><name><surname>Li</surname><given-names>KW</given-names></name><name><surname>Palmen</surname><given-names>J</given-names></name><name><surname>Miller</surname><given-names>MA</given-names></name><name><surname>Cappuccio</surname><given-names>FP</given-names></name><name><surname>Elkeles</surname><given-names>R</given-names></name><name><surname>Godsland</surname><given-names>I</given-names></name><name><surname>Miller</surname><given-names>GJ</given-names></name><name><surname>Talmud</surname><given-names>PJ</given-names></name></person-group><article-title>Common variants in the TCF7L2 gene and predisposition to type 2 diabetes in UK European Whites, Indian Asians and Afro-Caribbean men and women</article-title><source>J Mol Med</source><year>2006</year><volume>84</volume><fpage>1005</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">17665514</pub-id><pub-id pub-id-type="doi">10.1007/s00109-006-0108-7</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Duval</surname><given-names>A</given-names></name><name><surname>Busson-Leconiat</surname><given-names>M</given-names></name><name><surname>Berger</surname><given-names>R</given-names></name><name><surname>Hamelin</surname><given-names>R</given-names></name></person-group><article-title>Assignment of the TCF-4 gene (TCF7L2) to human chromosome band 10q25.3</article-title><source>Cytogenet Cell Genet</source><year>2000</year><volume>88</volume><fpage>264</fpage><lpage>265</lpage><pub-id pub-id-type="pmid">10828605</pub-id><pub-id pub-id-type="doi">10.1159/000015534</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yi</surname><given-names>F</given-names></name><name><surname>Brubaker</surname><given-names>PL</given-names></name><name><surname>Jin</surname><given-names>T</given-names></name></person-group><article-title>TCF-4 mediates cell type-specific regulation of proglucagon gene expression by beta-catenin and glycogen synthase kinase-3beta</article-title><source>J Biol Chem</source><year>2005</year><volume>280</volume><fpage>1457</fpage><lpage>1464</lpage><pub-id pub-id-type="pmid">15525634</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M411487200</pub-id></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ross</surname><given-names>P</given-names></name><name><surname>Hall</surname><given-names>L</given-names></name><name><surname>Smirnov</surname><given-names>I</given-names></name><name><surname>Haff</surname><given-names>L</given-names></name></person-group><article-title>High level multiplex genotyping by MALDI-TOF mass spectrometry</article-title><source>Nat Biotech</source><year>1998</year><volume>16</volume><fpage>1347</fpage><lpage>1351</lpage><pub-id pub-id-type="doi">10.1038/4328</pub-id></citation></ref><ref id="B16"><citation citation-type="other"><article-title>Haploview</article-title><ext-link ext-link-type="uri" xlink:href="http://www.broad.mit.edu/personal/jcbarret/haploview"/></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Qu</surname><given-names>HQ</given-names></name><name><surname>Lu</surname><given-names>Y</given-names></name><name><surname>Marchand</surname><given-names>L</given-names></name><name><surname>Bacot</surname><given-names>F</given-names></name><name><surname>Frechette</surname><given-names>R</given-names></name><name><surname>Tessier</surname><given-names>MC</given-names></name><name><surname>Montpetit</surname><given-names>A</given-names></name><name><surname>Polychronakos</surname><given-names>C</given-names></name></person-group><article-title>Genetic Control of Alternative Splicing in the TAP2 Gene Possible Implication in the Genetics of Type 1 Diabetes</article-title><source>Diabetes</source><year>2007</year><volume>56</volume><fpage>270</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">17192492</pub-id><pub-id pub-id-type="doi">10.2337/db06-0865</pub-id></citation></ref><ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Korinek</surname><given-names>V</given-names></name><name><surname>Barker</surname><given-names>N</given-names></name><name><surname>Morin</surname><given-names>PJ</given-names></name><name><surname>van Wichen</surname><given-names>D</given-names></name><name><surname>de Weger</surname><given-names>R</given-names></name><name><surname>Kinzler</surname><given-names>KW</given-names></name><name><surname>Vogelstein</surname><given-names>B</given-names></name><name><surname>Clevers</surname><given-names>H</given-names></name></person-group><article-title>Constitutive Transcriptional Activation by a beta -Catenin-Tcf Complex in APC-/- Colon Carcinoma</article-title><source>Science</source><year>1997</year><volume>275</volume><fpage>1784</fpage><lpage>1787</lpage><pub-id pub-id-type="pmid">9065401</pub-id><pub-id pub-id-type="doi">10.1126/science.275.5307.1784</pub-id></citation></ref><ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Morin</surname><given-names>PJ</given-names></name><name><surname>Sparks</surname><given-names>AB</given-names></name><name><surname>Korinek</surname><given-names>V</given-names></name><name><surname>Barker</surname><given-names>N</given-names></name><name><surname>Clevers</surname><given-names>H</given-names></name><name><surname>Vogelstein</surname><given-names>B</given-names></name><name><surname>Kinzler</surname><given-names>KW</given-names></name></person-group><article-title>Activation of beta -Catenin-Tcf Signaling in Colon Cancer by Mutations in beta -Catenin or APC</article-title><source>Science</source><year>1997</year><volume>275</volume><fpage>1787</fpage><lpage>1790</lpage><pub-id pub-id-type="pmid">9065402</pub-id><pub-id pub-id-type="doi">10.1126/science.275.5307.1787</pub-id></citation></ref><ref id="B20"><citation citation-type="other"><article-title>HapMap</article-title><ext-link ext-link-type="uri" xlink:href="http://www.hapmap.org"/></citation></ref><ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Helgason</surname><given-names>A</given-names></name><name><surname>Palsson</surname><given-names>S</given-names></name><name><surname>Thorleifsson</surname><given-names>G</given-names></name><name><surname>Grant</surname><given-names>SFA</given-names></name><name><surname>Emilsson</surname><given-names>V</given-names></name><name><surname>Gunnarsdottir</surname><given-names>S</given-names></name><name><surname>Adeyemo</surname><given-names>A</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>G</given-names></name><name><surname>Reynisdottir</surname><given-names>I</given-names></name><name><surname>Benediktsson</surname><given-names>R</given-names></name><name><surname>Hinney</surname><given-names>A</given-names></name><name><surname>Hansen</surname><given-names>T</given-names></name><name><surname>Andersen</surname><given-names>G</given-names></name><name><surname>Borch-Johnsen</surname><given-names>K</given-names></name><name><surname>Jorgensen</surname><given-names>T</given-names></name><name><surname>Schafer</surname><given-names>H</given-names></name><name><surname>Faruque</surname><given-names>M</given-names></name><name><surname>Doumatey</surname><given-names>A</given-names></name><name><surname>Zhou</surname><given-names>J</given-names></name><name><surname>Wilensky</surname><given-names>RL</given-names></name><name><surname>Reilly</surname><given-names>MP</given-names></name><name><surname>Rader</surname><given-names>DJ</given-names></name><name><surname>Bagger</surname><given-names>Y</given-names></name><name><surname>Christiansen</surname><given-names>C</given-names></name><name><surname>Sigurdsson</surname><given-names>G</given-names></name><name><surname>Hebebrand</surname><given-names>J</given-names></name><name><surname>Pedersen</surname><given-names>O</given-names></name><name><surname>Thorsteinsdottir</surname><given-names>U</given-names></name><name><surname>Gulcher</surname><given-names>JR</given-names></name><name><surname>Kong</surname><given-names>A</given-names></name><name><surname>Rotimi</surname><given-names>C</given-names></name><name><surname>Stefansson</surname><given-names>K</given-names></name></person-group><article-title>Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution</article-title><source>Nat Genet</source><year>2007</year><volume>39</volume><fpage>218</fpage><lpage>225</lpage><pub-id pub-id-type="pmid">17206141</pub-id><pub-id pub-id-type="doi">10.1038/ng1960</pub-id></citation></ref><ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>American Diabetes</surname><given-names>A</given-names></name></person-group><article-title>Standards of Medical Care in Diabetes--2007</article-title><source>Diabetes Care</source><year>2007</year><volume>30</volume><fpage>S4</fpage><lpage>41</lpage><pub-id pub-id-type="pmid">17192377</pub-id><pub-id pub-id-type="doi">10.2337/dc07-S004</pub-id></citation></ref><ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Elbein</surname><given-names>SC</given-names></name><name><surname>Chu</surname><given-names>WS</given-names></name><name><surname>Das</surname><given-names>SK</given-names></name><name><surname>Yao-Borengasser</surname><given-names>A</given-names></name><name><surname>Hasstedt</surname><given-names>SJ</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Rasouli</surname><given-names>N</given-names></name><name><surname>Kern</surname><given-names>PA</given-names></name></person-group><article-title>Transcription factor 7-like 2 polymorphisms and type 2 diabetes, glucose homeostasis traits and gene expression in US participants of European and African descent</article-title><source>Diabetologia</source><year>2007</year><pub-id pub-id-type="pmid">17579832</pub-id></citation></ref><ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Field</surname><given-names>SF</given-names></name><name><surname>Howson</surname><given-names>JM</given-names></name><name><surname>Smyth</surname><given-names>DJ</given-names></name><name><surname>Walker</surname><given-names>NM</given-names></name><name><surname>Dunger</surname><given-names>DB</given-names></name><name><surname>Todd</surname><given-names>JA</given-names></name></person-group><article-title>Analysis of the type 2 diabetes gene, TCF7L2, in 13,795 type 1 diabetes cases and control subjects</article-title><source>Diabetologia</source><year>2006</year><pub-id pub-id-type="pmid">17063324</pub-id></citation></ref></ref-list></back></article> 